newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine

Oravax's virus-like particle (VLP) vaccine being tested against COVID-19 variants including Delta Oral COVID-19 vaccine being developed as both a standalone vaccine and a booster for people previously vaccinated MYMD is evaluating options for